Unbound MEDLINE

Thrombocytopenia associated with intravenous ciprofloxacin. Pharmacotherapy. [Pharmacotherapy] Journal article

 
TitleThrombocytopenia associated with intravenous ciprofloxacin.
Author(s)Starr JA, Ragucci KR 
InstitutionCollege of Pharmacy, Medical University of South Carolina, Charleston, South Carolina 29425, USA. starrje@musc.edu
SourcePharmacotherapy 2005 Jul; 25(7):1030-4.
MeSHAged
Anti-Infective Agents
Ciprofloxacin
Female
Humans
Injections, Intravenous
Thrombocytopenia
Urinary Tract Infections
AbstractA variety of disease states, disorders, hereditary conditions, environmental toxins, and drugs may cause thrombocytopenia. Fluoroquinolones, however, are not thought to be common offenders. We report the case of a 72-year-old woman who was receiving intravenous ciprofloxacin for a urinary tract infection and developed thrombocytopenia during her hospital stay. Her platelet count dropped from 147 x 10(3)/mm3 on admission to as low as 21 x 10(3)/mm3 . On discontinuation of the drug, her platelet counts began to return to normal. After discharge, the patient continued to improve clinically. Four days after discharge, her platelet count was 197 x 10(3)/mm3 . In the primary literature, we found two case reports on thrombocytopenia associated with ciprofloxacin and one case report with alatrofloxacin. In addition, six additional case reports were found in non-English journals that describe fluoroquinolone-associated thrombocytopenia. Clinicians should be aware of the possible relationship between thrombocytopenia and fluoroquinolones, and platelet counts should monitored accordingly.
Languageeng
Pub Type(s)Case Reports
Journal Article
PubMed ID16006282
  
Advertise on this site.